Impact of risperidone long-acting injectable on hospitalization and medication use in patients with schizophrenia

被引：3
|
作者：
Beauclair, L
Lam, A
McCormick, J
Luong, D
Camacho, F
机构：
[1] McGill Univ, Montreal, PQ, Canada
[2] Janssen Ortho Inc, Toronto, ON, Canada
[3] McKesson Phase 4 Solut, Toronto, ON, Canada
[4] Damos Inc, Toronto, ON, Canada
来源：
VALUE IN HEALTH | 2005年 / 8卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)67769-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A202 / A203
页数：2
相关论文
共 50 条
  • [21] The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
    Miyamoto S.
    Wolfgang Fleischhacker W.
    Current Treatment Options in Psychiatry, 2017, 4 (2) : 117 - 126
  • [22] Risperidone long-acting injectable in dual diagnosed patients
    Batlle, E
    Andres, I
    Bastardas, J
    Fernandez, T
    Ferrer, J
    Lozano, L
    Martinez, J
    Menus, R
    Mola, M
    Vazquez, G
    Vazquez, JM
    EUROPEAN PSYCHIATRY, 2005, 20 : S30 - S31
  • [23] Impact of risperidone long-acting injection versus oral antipsychotic treatments on hospitalization in schizophrenia
    Olivares, J. M.
    Rodriguez-Morales, A.
    Diels, J. K.
    Povey, M.
    Lam, A.
    Jacobs, A.
    Zhao, Z.
    VALUE IN HEALTH, 2008, 11 (03) : A121 - A122
  • [24] Impact of risperidone long-acting injection verus oral antipsychotic treatments on hospitalization in schizophrenia
    Olivares, J. M.
    Rodriguez, A. Morales
    Diels, J.
    Povey, M.
    Lam, A.
    Zhao, Z.
    EUROPEAN PSYCHIATRY, 2008, 23 : S126 - S126
  • [25] A randomized trial of paliperidone palmitate and risperidone long-acting injectable in schizophrenia
    Fleischhacker, W. Wolfgang
    Gopal, Srihari
    Lane, Rosanne
    Gassmann-Mayer, Cristiana
    Lim, Pilar
    Hough, David
    Remmerie, Bart
    Eerdekens, Marielle
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2012, 15 (01): : 107 - 118
  • [26] Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations
    Parellada, Eduard
    PSYCHOPHARMACOLOGY BULLETIN, 2007, 40 (02) : 82 - 100
  • [27] Long-acting risperidone - A review of its use in schizophrenia
    Harrison, TS
    Goa, KL
    CNS DRUGS, 2004, 18 (02) : 113 - 132
  • [28] Long-Acting Risperidone: A Review of Its Use in Schizophrenia
    Harrison T.S.
    Goa K.L.
    CNS Drugs, 2004, 18 (2) : 113 - 132
  • [29] Use of Long-Acting Injectable Paliperidone to Increase Medication Compliance in Individuals with ESRD and Schizophrenia
    Ruppert, Ryan
    Bryant, Cody
    Lifland, Brooke
    Cho, Stephanie
    JOURNAL OF THE ACADEMY OF CONSULTATION-LIAISON PSYCHIATRY, 2023, 64 : S100 - S101
  • [30] Long-term safety and tolerability of long-acting injectable risperidone in patients with schizophrenia or schizoaffective disorder
    Lindenmayer, Jean-Pierre
    Khan, Akbar
    Eerdekens, Marielle
    Van Hove, Ilse
    Kushner, Stuart
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 (02) : 138 - 144
12345